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Abstract: Chronic wounds such as diabetic foot ulcers, pressure ulcers, venous leg 
ulcers have become a worldwide problem, as they fail to heal in a regular period due to the 
presence of an extended inflammatory stage. Bacterial infection is one contributing factor 
that impairs the wound healing process. The ability of the dermal fibroblast to migrate, 
proliferate and differentiate is the critical factor for the normal progression of wound 
healing. Studies have shown that chronic wound biofilms colonize the dermal tissue which 
makes it important to investigate dermal fibroblast behavior in the presence of bacterial 
secreted products. The objective of the study was to determine if products secreted by 
Staphylococcus aureus in planktonic or biofilm phenotypic states would play a role in 
wound chronicity by affecting fibroblast functions. 
A 3-dimensional collagen lattice model was used to study fibroblast tension generation day 
by day with the presence or absence of the bacterial secretion products. Using this model, 
we conducted our observation by measuring height and fibroblast tension generation of 
collagen lattices and followed by immunostaining the lattices to identify structural changes.  
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On each day of 5-day height measurements of fibroblast lattices, I observed that planktonic 
conditioned medium (PCM)-treated lattices had the most significant effect on compaction 
compared to biofilm conditioned medium (BCM), control and TGF-beta treatments. 
Similarly, when lattices were released PCM inhibited the lattice contraction followed by 
BCM. Lattices treated with TGF- beta were found to have the highest anchored compaction 
and were very contractile when released. Compaction and contraction were associated with 
the number of differentiated myofibroblasts and total cell number with respect to the 
treatment. Fibroblast lattices exposed to PCM showed no presence of myofibroblasts. Our 
findings are highly relevant to the medical field curing chronic wounds and should help the 










Wound healing is the process of repairing the injured skin by itself (Li and Wang, 2011). 
After an injury, to maintain the integrity of skin, it involves normal interconnected and 
overlapping phases of inflammation, proliferation, contraction, and tissue remodeling. 
Wound healing involves various cell types such as keratinocytes, fibroblasts, endothelial 
cells, macrophages, and platelets. To maintain skin integrity, the migration, infiltration, 
proliferation, and differentiation of these cells are necessary (Barrientos et al., 2008). Skin 
wound healing is categorized as either acute and or chronic. Acute wounds heal within a 
predictable time and involve all phases of healing whereas chronic wounds fail to follow 
the typical phases of wound healing and do not heal or require an extended period, which 
takes more than three months to heal. 
In acute healing, to restore the skin, the damaged capillaries trigger the clotting of blood. 
While clotting blood, the wound tissue releases multiple pro-inflammatory cytokines such 
as fibroblast growth factor (FGF), transforming growth factor-beta (TGF-β) and epidermal 
growth factor (EGF) (S. Guo and L.A. DiPietro., 2010). Tissue repair starts with 
inflammation where the infiltration of neutrophils, monocytes, lymphocytes, and 
differentiation of macrophages occur, and these cells migrate toward the wound site (Ian 
A Darby et al., 2014). Neutrophils phagocytose the invading microbes. Macrophages play 
critical roles in healing. Macrophages recruit lymphocytes, induce apoptosis and clear 
apoptotic cells. The phenotypic state of a macrophage changes to a reparative state to 
promote tissue regeneration that stimulates keratinocytes, fibroblasts, and angiogenesis (S. 
Guo and L.A. DiPietro, 2010). The reparative state of macrophages is identified by the 
expression of anti-inflammatory mediators such as Il-R antagonist, decoy IL-1 receptor 
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type II and IL-10 and production of growth factors such as transforming growth factor 
(TGF-β1), vascular endothelial growth factors (VEGF), and insulin-like growth factor 
(IGF)-1. The transition of macrophage to reparative state is the signal that switch the 
inflammation to proliferation during wound healing (Koh and DiPietro, 2011).  
The proliferative phase follows and overlaps with the inflammatory phase. Fibroblasts and 
endothelial cells are considered as the most important cell types that support capillary 
growth, the formation of collagen and granulation tissue at the wound site. TGF-β and other 
growth factors produced in this phase stimulate the fibroblast. Stimulated fibroblasts 
produce the collagen within the wound site which is the main protein component of the 
extracellular matrix (ECM). Collagen and fibronectin provide the structural integrity to 
granulation tissue that enables the fibroblast to change its phenotype into a contractile form 
called the myofibroblast (Darby and Hewitson, 2007). The myofibroblast present in 
wounds plays a role in wound closure through its contractile nature. The robust 
proliferation and ECM synthesis take wound healing to its final phase, i.e., the remodeling 
phase (Gosain and Dipietro, 2004).  
In the remodeling phase, the maximum tensile strength is achieved through reorganization 
of tissue, in the extracellular matrix. To achieve a normal tissue, the granulation tissue 
finally gets remodeled, forming scar tissue that is less cellular and vascular (Stunova & 
Vistejnova, 2018). Type I collagen replaces the type III collagen secreted by fibroblasts in 
the previous phase. The high contraction and excessive collagen deposition form 
hypertrophic scarring during wound healing. (Menon et al., 2012).  
Chronic wounds fail to follow the orderly process of wound healing and take a more 
extended period to heal or may not heal at all. It is a common and major health issue. 
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Chronic wounds are common in people who suffer from leg ulcers, pressure ulcers, and 
diabetic foot ulcers as well as venous and arterial ulcers. In the United States, around three 
million people are suffering from pressure ulcers and venous ulcers (Soliman et al., 2018). 
The total cost to treat chronic wounds in the USA each year is over US$25 billion, with the 
growing number of patients prevalence of diabetes and other chronic diseases from 6.5 
million (Han and Ceilley, 2017). A chronic wound is the result of prolonged inflammation 
containing proinflammatory cytokines, high protease levels, and neutrophils failing to go 
through the normal healing process (Wolcott RD et al., 2008). In a chronic wound, the 
matrix supports inflammatory cells, an d macrophages while fibroblast functions are 
impaired; together these delay the healing process (Stadelmann, 1998). Further 
consequences of a continuing chronic wound include septicemia, chronic pain, 
amputations, and death (Jeffery et al., 2015). Therefore, it is essential to understand the 
cellular and molecular level of wound healing which will improve the medical approach 
treating chronic wounds.  
Multiple factors affect one or more phases of wound healing. Bacterial infection is one of 
the significant challenges that impedes wound healing and is responsible for delayed tissue 
repair in chronic wounds (Jeffery et al., 2015). Most chronic wounds are colonized by 
bacteria and progress to infection when their host has a weak immune response (Edwards 
and Harding., 2004). The chronic wound bacteria exist in two states: planktonic and 
biofilm. A free-living state of bacteria in a liquid is considered planktonic (Percival et al., 
2012) whereas a cluster of bacteria attached to a surface and surrounded by a protective 
extracellular polymeric matrix is considered biofilm (Percival et al., 2015). Both states of 
bacteria might play a role in the pathogenicity and delay of wound healing in a chronic 
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wound (Perez Diaz et al., 2016). The two-different phenotypic states of bacteria have 
different gene regulation and expression. Around 80 % of bacterially infected wounds 
prevail in the form of biofilms. Biofilms show more resistance to immune response and 
antibiotics than planktonic (Resch et al., 2005). The biofilm develops a protective 
microenvironment and is impervious to antibiotics. The wound bed under the bacterial 
biofilms remains in a persistent inflammatory state (Jeffery et al., 2015). Chronic wounds 
provide a favorable environment for a bacterial infection which leads to biofilm formation 
that can delay the healing process (Zhao et al., 2010). Staphylococcus aureus and 
Pseudomonas aeruginosa are the predominant bacteria associates common in chronic 
wounds. These bacteria play an essential role in wound pathogenesis (Guo and DiPietro., 
2010). The bacteria association attached to the surface as biofilm in chronic wound 
pathogenesis is not very well understood (Werthen et al., 2010).  Usually, there are more 
than one bacterial species associated with a wound infection. The most prevalent species 
in chronic wounds are Staphylococcus, Pseudomonas aeruginosa, Enterobacter, 
peptoniphilus, Enterobacter, Stenotrophomonas, Finegoldia and Serratia spp (Kirker and 
Garth., 2017; Xu and Z., 2018). We used S. aureus, a single strain bacterium for our study 
to better understand wound pathogenicity. It is one the most prevalent bacteria in chronic 
wounds that infects and colonizes the wound bed. S. aureus causes a wide variety of skin 
diseases and chronic wound infections. Various studies have been carried out to understand 
the pathogenicity of S. aureus in related chronic wound areas, but its pathogenicity is still 
unclear. Therefore, it is essential to investigate on how S. aureus may be impairing the 
healing process.   
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 The dermis of the skin is composed of dense irregular connective tissue. The fibroblast 
serves as the primary resident cell and is responsible for forming new granulation tissue, 
regulating angiogenesis, supporting re-epithelization, creating new extracellular matrix 
molecules and synthesizing collagen to provide support for other cells to enable effective 
wound healing (Stunova, A., and Vistejnova 2018). The fibroblast is mainly responsible 
for remodeling of tissue, which gives a better understanding of wound healing and other 
fibrotic disease progressions. A fibroblast synthesizes type I collagen and is most 
abundantly found in the dermis. During dermal wound healing, ECM signaling has 
different effects on fibroblast proliferation, migration, collagen production and 
differentiation (Tracy et al., 2016). 
 After an injury, the fibroblast starts migrating towards the wound site while it reorganizes 
the ECM along the lines of stress providing the mechanical tissue tension for the cell 
(Tomasek et al., 2002). With this tension, the fibroblast starts differentiating its phenotype 
to the myofibroblast, a cell that generates high contractile force and synthesizes ECM to 
facilitate wound closure(Li & Wang, 2011). It is characterized by having stress fibers that 
express cytoplasmic α-smooth muscle actin fibers (Tomasek, Gabbiani, Hinz, Chaponnier, 
& Brown, 2002) and demonstrating high contractile force (Hinz et al., 2007) through the 
interaction of actin with non-muscle myosin II. Tension generation is essential to enable 
the myofibroblasts phenotype (Tomasek et al., 2002) and during wound closure the 
presence of myofibroblasts in granulation tissue is essential. The activation of Rho 
promotes the assembly of stress fibers and fibroblasts contraction. The activity of myosin 
light chain kinase (MLCK) and myosin light chain phosphatase (MLCPPase) enzymes 
regulates fibroblast contraction (Parizi and et al., 2000). Growth factors produced by 
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platelets and cells present in the blood clot trigger further differentiation into the 
myofibroblast (Darby and Hewitson., 2007). TGF-β, ECM proteins and mechanical 
stiffness activate the differentiation of fibroblast (Van De Water et al., 2013). Alpha 
smooth muscle actin incorporation into stress fibers provides structural elements and focal 
adhesions containing proteins such as vinculin (Vaughan et al., 2000). In chronic wounds, 
the hypoxic environment decreases myofibroblast formation (Van De Water et al., 2013). 
Matrix remodeling and fibroblast proliferation change the mechanical properties of the 
tissue. These mechanical changes are important to study to provide knowledge of wound 
healing.  
Wound biofilms and chronicity can be studied using appropriate yet simplified in vitro 
models. Collagen matrices provide a well-established in vitro model that mimics wound-
healing granulation tissue and wound contraction (Tomasek et al., 1992; Grinnell, 1994; 
Carlson and Longaker, 2004; Herwig and Vaughan, 2014). The lattice model simulates 
wound healing mechanisms and offers numerous opportunities for reasonable investigation 
of the fibroblast role during wound contraction.  Collagen lattices are the combination of 
fibroblasts and type I collagen. The fibroblast-populated collagen lattice simulates 
granulation tissue that acts similarly to the processes of proliferation, apoptosis, protein 
synthesis, and contraction (Carlson and Longaker, 2004). In this model, the fibroblasts start 
spreading, migrating and reorganizing the collagen matrix using tractional force. The 
mechanical tension produced in the collagen lattice is vital for fibroblast differentiation. 
Myofibroblasts need a tension-maintaining environment which is satisfied by an anchored 
collagen lattice model. The lattices were treated with TGF-β as a positive control for 
increased migration and contraction as expected due to its presence in normal wound 
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healing. It is appropriate to use TGF-β because in lattices the treated fibroblasts are 
activated.  When the lattices are physically released, tension is relieved, and the lattice will 
contract; subsequently, the cells may undergo apoptosis (Grinnell., 1999) or revert to a 
fibroblast phenotype. These things suggest that the model we use is entirely appropriate for 
studying at least two phases of wound healing, i.e. granulation and contraction.  By 
recognizing the need to study tension regeneration and its ability to help increase the rate 
of chronic wound healing, our understanding of wound biofilms and wound chronicity can 
improve. This study will help improve the knowledge of biofilms within the scientific 
community, which may foster future research to improve chronic wound. 
Objective of the study 
The purpose of the research was to investigate the Staphylococcus aureus biofilm and 
planktonic secreted products’ effects on tension generation by normal dermal fibroblasts 
in collagen lattices, and whether these effects are related to proliferation and/or 
myofibroblast differentiation. This study helps to bridge the knowledge gap between 
wound contraction and extended inflammation, where myofibroblast differentiation that 
could lead to wound closure is prohibited. Since the pathogenicity of these bacterial 
biofilms on dermal tissue is unknown, it is important to investigate fibroblast behavior with 
the presence of bacterial biofilms’ secreted products (Kirker et al. 2012). Fibroblasts play 
a critical role in exerting force, first by using migration mechanisms and then by 
differentiating into myofibroblasts and generating tension. We hypothesized that the 
secreted bacterial products of S. aureus inhibit the fibroblast contraction of the lattices 
which is correlated to the proliferation and differentiation of myofibroblasts. We proposed 
to use a simplified in vitro model to better understand wound biofilms and chronicity. It is 
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important to investigate the effects of bacterial biofilm on dermal fibroblasts using an 
anchored 3-D collagen matrix since it closely resembles in vivo tissue-like attributes, 
including morphology, cell division, and protein expression compared to conventional 2-
D models (Grinnell, 1994) (Grinnell et al., 2006). Also, we observed the collagen lattice 
compaction over time which helped us monitor the tissue tension increase in a matrix to its 
maximum and afterward. 
Materials and Methods 
Fibroblast culture: Normal human dermal fibroblasts were cultured in a T-75 tissue 
culture flask using Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 5% 
fetal bovine serum, 2mM glutamine, and 1% antibiotic – anti-mycotic and incubated at 
37°C in a CO2 incubator. We carried out all experiments when cells were actively dividing 
and in log-phase growth. The UCO Institutional Review Board approved our studies. 
HaCaT culture: HaCaT an immortalized human epidermal keratinocyte, (Boukamp et 
al.,1988) were cultured in T-25 tissue culture flask maintained with DMEM containing 
10% Fetal bovine serum and Penicillin/ Streptomycin in a CO2 incubator at 37°C. In a 24-
well plate, the cell concentration of 3x104 per well were prepared to run an experiment.  
Biofilm Conditioned media (BCM): Staphylococcus aureus ATCC 6538 strain is one of 
the prevalent biofilm forming bacteria, so we prepared its biofilm in tissue culture inserts. 
Briefly, tryptic soy broth (TSB) was used to grow bacteria and adhere to on the surface of 
tissue culture inserts. An overnight culture of S. aureus was inoculated in 5 ml of TSB. The 
inoculated bacteria of 10 µl was placed into tissue culture inserts. Every 24 hrs. for a total 
of 72 hrs. The broth was replaced, and inserts were then moved to new wells of 24-well 
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plates. After 72 hrs., the inserts with bacteria were washed with phosphate buffer solutions 
to remove excess TSB. Finally, DMEM without serum was supplied for 72 hrs. and every 
24 hrs. Then exposed media was collected and tissue culture inserts were transferred to 
new wells. The secretions produced by S. aureus biofilm were collected and filtered using 
a 0.45μm syringe and were stored at -20°C. (Tankersley et al. 2014). 
Planktonic Conditioned Media (PCM): PCM was prepared by overnight culture of S. 
aureus bacteria that was inoculated in 5ml of TSB and was placed on a rotary shaker for 
agitation at 150 rpm at 37°C. After 24 hrs. of incubation the tube of bacteria was 
centrifuged at 1500 rpm for 7 minutes and the TSB was removed. Then 5ml of PBS with 
pH 7.4 was used to wash the pellet. 5ml of DMEM without serum was then supplied for 
another 24 hrs., if necessary 48 hrs. in agitation at 150 rpm. Finally, the culture was 
centrifuged and the supernatant DMEM was collected, filtered and stored at -20°C 
(Tankersley et al., 2014). 
Conditioned medium 
 Biofilm conditioned media was produced by growing S. aureus ATCC 6538 biofilms on 
a tissue culture inserts and the planktonic S. aureus was grown in a cell culture medium 
with agitation to produce the planktonic conditioned medium. In some cases, the pH of 
both BCM and PCM in the media was too acidic. The pH indicator in the media (phenol 
red) indicated acidic conditions (turned yellow) in both PCM and BCM under submerged 
condition (Tankersley et al., 2014). Subsequent emerging of the bacteria in the media as 




Detection of Inflammatory cytokines: 
This experiment was carried out to observe if bacterial secretion products cause any 
inflammation. HaCaT cells were plated in a 24-well tissue culture plate at a concentration 
of 105 cells/well. After the cells reached 80-90 % confluency, they were treated with BCM, 
PCM and the vehicle control (DMEM lacking serum and antibiotics) for 24 hrs at 37°C. 
After 24 hours of exposure the BCM, PCM, and control media were collected and stored 
at -20°C. Some of the BCM, PCM, and control from each specific group was used as a 
treatment for a collagen lattice to study effects on myofibroblast and the remainder were 
stored until the ELISA was performed. An ELISA kit (R&D Systems) was used as per 
instructions to test for IL8/CXCL8 after the supernatants were collected from the treatment 
and control group (Tankersley et al. 2014). 
Optimization of the Collagen Lattice Assay: The preparation of collagen lattices is a 
critical step which requires an optimal time for mixing of cell and collagen components 
and then plating in a pre-warmed dish. We used three different collagen distributing 
companies’ products: Millipore, Corning, and Invitrogen. Three different vendors collagen 
products were mixed and plated at different time periods. The number of cells falling 
through to the plate underneath the collagen lattice and the texture of collagen was 
observed, to determine the effective plating time required to achieve homogeneous 
collagen composition and uniform cell distribution. Image J texture plugin was used to 
analyze the flocculence of the collagen.   
Anchored collagen lattice preparation: The group of anchored collagen lattice assay was 
prepared with a mixture of dermal fibroblasts and type I collagen (Vaughan et al., 2000). 
To equilibrate the acidic and hypotonic collagen, the components 0.1N NaOH, 10X 
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EMEM, 10X NaHCO3 were mixed to bovine collagen (final concentration 1mg/ml) to 
make an isotonic collagen solution of pH 7.4.  Then, cells and collagen solution were mixed 
with the collagen solution on ice for the optimized time (4 minutes) and 80 µl drops were 
plated on 40 mm tissue culture plates (TPP; Midwest Scientific) then allowed to polymerize 
at 37°C for one hour. Subsequently, 2 ml of growth media in the presence or absence of 
bacterial biofilm extracts were added to each plate. TGF-β (1µg/ml) was used as a positive 
control to stimulate the fibroblast differentiation to myofibroblast.  Then, lattices were 
incubated in a 5% CO2 incubator for specific times, ranging from 24 hours to 5 days to 
allow us to find the peak of tension in the presence or absence of extracts or HaCaT- 
exposed bacterial secretions. During the 5-day incubation, the lattices’ height was 
measured every day (as a measure of compaction). On the final day, the anchored lattices 
were released from the bottom of the dish, and contraction (diameter reduction over time) 
was measured. A replicate anchored lattice was used for immunostaining to quantify cell 
proliferation and differentiation as described below.   
Lattice height Measurement: Human fibroblast collagen lattice height was measured 
every 24 hrs to predict the associated fibroblast contraction (manuscript in preparation). 
The collagen lattice was placed on an inverted microscope stage (Leica Primovert). The 
matrix was observed under the highest magnification (200x total magnification) at the light 
source maximum. The lattice apex was moved to the middle of the light circle and focused 
through the collagen fibers which were on the upper surface of the lattice keeping the fine 
and coarse focus knob at the marked zero line. Using the fine focus, we visually focused 
through the collagen lattice to its bottom. The presence of a flattened cell in focus in the 
collagen was identified as the bottom of the matrix. We counted the number-line units on 
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each turn of fine focus knob while focusing through the entire depth of the lattice (from top 
to bottom). We measured the height of the matrix every day until day 5. The collected 
height values were imported into a spreadsheet for further analysis (Microsoft Excel). The 
height values were changed into micrometers using formula (= ((cell value/640) *1000)). 
The calibration of the depth measurement and preparation of the microscope were already 
performed in our lab, where we found that 640 units corresponded to one millimeter, the 
thickness of a microscope slide. Everyday measurement of lattice height helped us to 
predict the correlated contraction until day 5.  
Stress-relaxed collagen lattice assay: A 3-D stress-relaxed collagen lattice model was 
used to indirectly assess tension generated by normal dermal fibroblasts with the presence 
of Staphylococcus aureus BCM and PCM. It was performed on day 5 using a dissecting 
microscope (Olympus SZ-61) and a camera with software (SPOT Diagnostics) to collect 
images (Herwig and Vaughan, 2014). Lattices were first imaged and photographed while 
anchored. Some of the lattices were released from the bottom of the dish and pictures were 
taken at 1 minute, 2 minutes, 10 minutes, 30 minutes, and 60 minutes after release. They 
were released to observe the speed and intensity of contraction as an indirect method for 
studying tension generation (Tomasek et al., 1992). Collected images were then analyzed 
using a software program (ImageJ; Herwig and Vaughan, 2014). The mean lattice diameter 
change over time for each treatment was graphed with the standard deviation represented 
by error bars.  
Immunostaining to determine proliferation and myofibroblasts differentiation: An 
immunofluorescence technique was used to visualize labeled nucleotide incorporated 
during mitosis, and alpha-smooth muscle actin, the hallmark protein of the myofibroblasts 
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(Hinz et al., 2007). Ethynyl-deoxyuridine (EdU) is a modified nucleotide that binds DNA 
that is being replicated before cell proliferation. On day 5, two to three numbers of lattices 
from control and extract-treated groups were pulsed for one hour with an EdU nucleotide 
for proliferation analysis (Vaughan et al., 2014). EdU-pulsed lattices were fixed with 
paraformaldehyde, permeabilized with ice-cold methanol, and stained with mouse anti-
human alpha-smooth muscle actin (to identify myofibroblasts differentiation), followed by 
secondary antibody goat anti-mouse Alexa488 to visualize the actin antibody. A click- 
chemical reaction then linked a fluorescent probe (Alexa 594) to the incorporated EdU 
nucleotides (Vaughan et al.,2014). EdU staining facilitated the observation of fibroblast 
and myofibroblast proliferation within the lattice section. DAPI staining was used as a blue 
nuclear counterstain.  Lattices stains were photographed with an inverted fluorescence 
microscope (Olympus IX-71). A camera (DP72) photographed multiple images from the 
same field of view, and a software program (CellSens) was used to combine the blue 
(DAPI), red (EdU) and green (a-sm actin) photographs into a single image (figure 7) to 
enable quantification of 4 cell types: Non-proliferative fibroblasts (NPF), Proliferative 




To determine if there were significant differences in treatments with respect to mean 
change in contraction and mean height a repeated measure analysis of covariance 
(ANCOVA) was performed. For contraction the response variable was the change in 
contraction from baseline (time 0) at times 1, 2, 10, 30 and 60 minutes, and the factors were 
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treatment (control, biofilm, planktonic and TGF-β) and ln(time) with baseline contraction 
as the covariate. For compaction, the response variable was the change in height from 
baseline (day 0) at days 1, 2, 3, 4, and 5, and the factors were the treatment (control, biofilm, 
planktonic, TGF-β) and ln (days) with baseline height as the covariate. To achieve linearity, 
the time and days factors were log-transformed. In both cases, an unstructured covariance 
matrix for the repeated measurements was assumed. The ANCOVA was followed by 
Tukey’s multiple comparisons and was done using proc mixed in SAS. V.9.4. The 
correlation between the mean total number of cells and the mean height at day 5 was 
computed using SAS v.9.4. ANOVA test was performed to analyze the significant 














Optimization generated reproducible results 
Cell distribution changed with mixing time. We observed that when lattices were plated 
early with little or no mixing, cells would sink to lower regions of the collagen lattices and 
onto the plate below as shown in figure 1A and B. Graphed results showed different times 
of mixing were necessary to achieve even distribution (figure 2). 
Collagen lattice organization changed with mixing time. When collagen is brought to 
isotonic conditions (37°C, and pH 7.4), it begins to polymerize or gel. After too much 
mixing the collagen texture became flocculent (resembling cotton) (Elsdale and 
Bard.,1972) (figure 3A), likely because collagen pre-polymerized during the mixing 
process. We used Image J texture plugin to identify when flocculence became prevalent 
for each collagen type (figure 3B). In our study for each collagen, there was an optimum 
mixing time to allow best distribution of cells and lowest flocculence. Bovine collagen of 
concentration at 1mg/ml was optimized by mixing within a minute and plating by 4 minutes 
(figure 4). The optimum time for even distribution and homogenous collagen consistency 
is shown in figure 4. All subsequent experiments were set up during this optimum time.  
PCM inhibited lattice height compaction to a greater extent than BCM 
Anchored lattices in control conditions are height-compliant (susceptible to compaction in 
the z-axis) and the compaction by fibroblasts in control lattices was greater than 
compaction in the presence of bacterial secreted products. The control height compaction 
(figure 5, blue line) agrees with a previous study (Guidry and Grinnell,1985) where the 
lattice height decreased in the presence of growth media. The interaction between 
16 
 
treatments and ln(days) was significant (F=14.5, p = 0.001). The differences in the 
treatment means were analyzed each day separately. The mean height for all three 
treatments were all significantly different (p < 0.001). Each day of lattice height 
measurement (figure5), the PCM-treatment inhibited collagen lattice compaction to a 
greater extent than did the BCM treatment. Lattices treated with TGF-β were found to be 
at least inhibited, resulting in the smallest mean lattice height (greatest compaction).  
PCM inhibited collagen lattice contraction: 
The contraction of a lattice (i.e., reduction in diameter over time) provides an indirect 
measurement of tension generation (Tomasek, Haaksma, Eddy, & Vaughan, 1992). We 
predicted from our result of inhibited lattice compaction by the PCM treatment that 
subsequent lattice contraction would also be inhibited. The interaction between treatment 
and ln (time) was significant (F=10.5, p= 0.001). Also, at each time, the differences in the 
treatment means were analyzed separately at each time. There was no significant difference 
between control and biofilm at the 1-minute time point (t=-2.8, p=0.073) but at all other 
time point 2, 10, 30 and 60 minutes there were significant differences between all other 
treatments (p< 0.001) (Figure 6). PCM-treated lattices were significantly different (p< 
0.001) from TGF-β, control, and BCM at every released time point. The PCM treated 
lattices contracted the least, and TGF-β-treated lattices contracted the most with the 
smallest resultant lattice diameter (Figure 6).   
Ratios of the 4-measured cell types changed with treatments 
The inhibition of lattice compaction and contraction was correlated with cell number as 
previously published (Tomasek et al., 1992) and myofibroblast differentiation as 
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previously published (Vaughan et al., 2000). The total number of cells for each type of cell 
and treatment are displayed in the Table 1. There was a significant association between 
type of cell and treatment (χ2 = 14.1, p = 0.003) for NPF and PF.  In the PCM-treated 
lattices there were significantly more NPF cells, and in the TGF-β treatment, there were 
fewer NPF cells than expected. The proliferative fibroblasts were significantly fewer in the 
planktonic treated lattices whereas the TGF-β treated had significantly more PF cells. The 
values of myofibroblast differentiation and cell number are indicated in Table 1. There 
were little or no proliferating myofibroblasts in PCM-treated lattices.   
Inflammatory cytokines response in HaCaT cells exposed to secretion products 
ELISA detected the production of inflammatory cytokine IL-8 /CXCL8, a pro- 
inflammatory cytokine. It is important to detect IL-8 because of a pro-fibrogenic 
chemokine involved in fibrotic skin disease (Sahin and Wasmuth, 2013). The presence of 
IL-8 was detected highest in BCM than PCM or control (figure 8) as a result suggested 
previously (Tankersley and Brennan 2014). PCM exposed to HaCaT cells did not produce 
a significant amount of IL-8. A significant difference (p < 0.05) was observed between all 
the groups.  
HaCaT exposed PCM inhibited the collagen lattice height 
Bacterial secretion products were exposed to HaCaT cells and were collected to treat 
collagen lattices. There was significant difference (F = 400.0, p < 0.001) between treatment 
and ln(days). The differences in the treatment each day were separately analyzed. At day 
1, there was a significant difference between control and planktonic (t = -12.9, p < 0.001) 
and biofilm and planktonic (t = -8.1, p < 0.001), but control and biofilm were not 
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significantly different (t = -2.2, p = 0.143). Planktonic treatment resulted in the highest 
mean lattice height (least compaction) and control with the smallest mean lattice height 
(greatest compaction) (Figure 10). The mean heights of the three treatments at all other 
days were significantly different (p < 0.05) from each other. 
HaCaT exposed PCM inhibited the contraction 
The tension generation with the presence or absence of HaCaT-exposed bacterial secretion 
was analyzed via stress relaxed contraction. The interaction between treatment and ln(time) 
was not significant (F = 1.9, p = 0.205), but the main effect for treatment was (F = 146.0, 
p < 0.001).  Tukey’s multiple comparisons for treatment indicate there is a significant 
difference in the mean contraction of all three treatments (p < 0.05), with planktonic 
resulting in the least contraction and control affected to most contraction (figure 11). 
HaCaT- exposed secretion affected proliferation and differentiation 
Four different phenotypes of cells were quantified after the treatment with HaCaT exposed 
BCM and PCM. The total number of cells for each type of cell and treatment are displayed 
in Table 2. There was no significant association between NPMF and PMF of different 
treatment (χ2 = 4.2, p = 0.124). For NPF and PMF, there was also no significant association 
between type of treatments (χ2 = 2.8, p = 0.244). Whereas visually we noticed number of 
cells were fewer in PCM treated lattices compared to control. Also, there were fewer 







This research was focused on addressing the effect of bacterial conditioned media exposed 
to human fibroblasts and evaluating its function on compaction, contraction, proliferation 
and differentiation using the appropriate model. We used the anchored 3-D collagen lattice 
model to assess fibroblast functions accurately. We optimized the collagen matrix model 
for proper study because it has much variability. Therefore, optimization was necessary to 
avoid variability and achieve reproducible results. The soluble products produced by 
planktonic S. aureus inhibited compaction and contraction in a fibroblast collagen lattice, 
and it was correlated with cell number and myofibroblast. Also, the fibroblast response to 
bacterial secretion products was examined by quantifying inflammatory cytokine IL8.  
To set up the experiment, finding the optimum mixing and plating time was extremely 
important. Our previous results with BCM and PCM varied with each experiment. We 
observed that this variability was correlated with uneven distribution of cells or 
heterogeneous mixture of collagen (M. B. Vaughan, personal observations). These 
properties change with mixing and plating time. To increase reproducibility, we dedicated 
a set of lattices to finding the appropriate mixing and plating time. We found that for each 
different collagen tested it was necessary to find the peak time for mixing and plating. The 
optimized lattice allowed us to avoid uneven cell distribution and collagen pre-
polymerization. By optimizing, we could generate reproducible results for lattices exposed 
to bacterial conditioned media.  
 In our study, the lattice height measurement gave us the prediction of how much lattice 
tension had been generated and how much the lattices would contract upon release. The 
reduction of collagen lattice height depends on the ability of cell migration (tractional force 
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migration; Dallon and Elrich, 2008) and reorganization of the collagen matrix. After injury 
fibroblasts migrate into the wound (Tomasek et al., 2002) and reorganize granulation tissue 
using migratory properties (Ehrlich & Hunt, 2012). Cells in the collagen lattice can produce 
tractional force in the matrix. If there is tractional force present in the collagen matrix, then 
the height of lattice is reduced, but if no tractional force is within the matrix, then the lattice 
height remains unchanged.  With our study, it has been clear that PCM is capable of 
inhibiting lattice height reduction.  The cells in the PCM-treated lattice could not spread 
and reorganize the collagen matrix which inhibited lattice compaction more than any other 
treatment. The lattice height measurement is directly correlated with the lattice contraction. 
The contraction of collagen lattices is produced by the contractile force generated by 
myofibroblasts under stressed conditions rather than by migratory properties (Jiang et al., 
2008). In vivo, fibroblasts during the wound healing process promote contraction of 
granulation tissue that provides the permissive environment for the myofibroblast 
phenotype (Tomasek et al., 2002). In our study, PCM treatment inhibited the permissive 
environment for the myofibroblast phenotype. Therefore, it caused the inhibition in 
contraction of a lattice that might be related with the chronic wound presence of bacteria 
inhibition in closing the wound.   The TGF-β treated collagen lattices contracted the most 
and the results resembled to the finding of Vaughan et al. (2000) where they showed that 
TGF-beta promoting the formation of myofibroblasts resulted in increased contractile force 
generation. Also, in our study collagen lattices treated with TGF-β increased compaction 
by a mechanism like floating matrix contraction as previously shown (Montesano and Orci 
1988). Our collagen assay with TGF-β contracting most resembled previous findings 
(Grinnell and Ho, 2003). Our findings with bacterial conditioned media determined that 
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PCM significantly inhibited the contraction of fibroblast collagen lattices compared to the 
BCM and control.  
Because contraction of collagen lattice is affected by the number of cells present (Tomasek 
et al.,1992) and number or percentage of myofibroblasts (Tomasek et al.,2002), our next 
goal was to study these properties. To investigate, we stained our lattices to determine 
proliferation and myofibroblast differentiation. Visual inspection of PCM treated lattices 
showed a reduced number of cells; because cells in the anchored lattice can persist, 
proliferate, or undergo apoptosis (Grinnell et al., 1999), any of these properties can affect 
the number of cells, which by itself affects compaction (Grinnell et., 1999) or contraction 
(Tomasek et al. 1992, Vaughan et al., 2000). While we did not monitor apoptosis, we can 
confirm the cell death in the future by using a TUNEL assay or staining to demonstrate 
caspase-3 upregulation (Archana et al., 2013). Similar but much lesser effects were seen in 
BCM-treated lattices. We found that the PCM-treated lattices had little or no 
myofibroblasts present whereas the TGF-β-treated lattices had the highest number of 
myofibroblasts. Our results agreed with the study carried out in a coverslip experiment 
(Hall et al., 2016) where cells are growing under maximum tension. Fibroblasts treated in 
the presence or absence of BCM or PCM on a coverslip, then immunostained showed 
PCM-treated coverslips had decreased myofibroblast differentiation compared to BCM, 
similar to lattices, which suggests that PCM is not inhibiting permissive environment but 
something else that leads to myofibroblast formation. This can be tested by treating lattices 
under maximum tension with PCM. 
The inflammatory response of the host plays a critical role in healing wounds. The 
production of inflammatory cytokines is one of the inflammatory response. In our study, 
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because of the number of myofibroblasts and the total number of cells in the presence of 
PCM were reduced, we wanted to know whether signaling molecules were responsible. 
Therefore, we measured the production of IL-8 in bacterial secreted products. The BCM 
had the highest percentage of IL-8/CXCL8 than PCM and control resembling the findings 
with Tankersley et al. 2014. IL8 is one of the fibrogenic cytokines that is responsible for 
myofibroblast activation and proliferation (Bagalad, Mohan Kumar, & Puneeth, 2017). 
CXCL8 stimulates the differentiation of fibroblasts into myofibroblasts (Rees et al., 2015). 
Debreva, I et al., 2006 discovered that Il-8 secreted by fibroblasts in response to low density 
lipoprotein in a P38 MAPK-dependent manner resulted in cell spreading and allowed 
wound closure. In our study, we think that IL-8 production is the reason why BCM is less 
inhibitory. The prostate stromal fibroblast undergoes phenoconversion to the myofibroblast 
easily when exposed to a combination of CXCL8 and TGF-β1 (Gharaee-Kermani et al., 
2012). Also, IL8-  has ability to promote angiogenesis and cell proliferation in some cancer 
types. If we could inhibit IL-8, BCM might have mimicked the PCM results. In association 
with inflammation specific genes that are overexpressed in the PCM (IL1F9, IL28RA, and 
CXCR7; Tankersley et al., 2014) they have a biased expression in skin.  These 
overexpressed genes might be some of the reasons that PCM is actively inhibiting 
fibroblast functions. 
For further evaluation of inflammation, we exposed HaCaT cells to the bacterial secreted 
products and then used the media from the exposed HaCaT cells to treat the fibroblast 
collagen lattice. We observed that the PCM exposed HaCaT media tended to inhibit the 
lattice compaction followed by BCM. The lattice compaction was directly correlated with 
the contraction followed by BCM. Visually the staining results suggested that the number 
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of cells and myofibroblast were comparatively less than control. Whereas statistically due 
to less number of about four replicate samples the number of cells was not significantly 
different in each treatment. In HaCaT exposed treatments we observed, an immediate 
contraction of the collagen matrix after release than compare to the regular treatment group. 
This signifies that the mechanical tension is responsible for sharp contraction rather than 
the cellular activity (Vaughan et al., manuscript in preparation). It suggests that the cellular 
activity could be achieve by letting cell in collagen to mature for more than 5 days. 
Therefore, our cell phenotype ratio data was not significant difference between HaCaT 
exposed treatments because of unmatured cells where the proliferation and differentiation 
might be late than for the regular treatment. The differentiation of fibroblasts to 
myofibroblasts depends on the tension environment, and for collagen, the tension is 
generated when fibroblasts use tractional forces to reorganize the collagen (Grinnell, 1994). 
In this study, we have seen that PCM has a more detrimental effect on fibroblast functions 
than does BCM. The collagen lattices treated with biofilm secretion were also able to 
inhibit compaction and contraction (correlated with the number of cells and 
myofibroblasts) compared to control and TGF-Beta. We think one reason might be the 
effectiveness of biofilm is greater when it is present in the wound rather than just in the 
secreted products. The study by Izano et al., 2008, where they degraded the biofilm by 
enzymes dispersin B and lysostaphin, and we predicted that biofilm secretion effect is more 
within its polysaccharide sheath and when a protective sheath is disrupted the biofilm 
secretion might be effective on inhibiting the fibroblast function. This study is currently 
underway in our lab to see if the biofilm secretion after disruption releases compaction/ 
contraction inhibitors.  
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Conclusion and Future studies 
In our study, the investigation of the effects of bacterial secretion products on fibroblast 
tension generation, migration, proliferation, and differentiation enhance the understanding 
of the role of S. aureus in chronic wound pathogenesis.  We found that PCM has a more 
significant effect on the fibroblast collagen lattice height and force generation by 
contraction. PCM created a permissive environment of inhibition (reduced compaction and 
reduced number of cells) resulting in reduced myofibroblast differentiation and contraction 
(Figure 9).  The fibroblast migration, proliferation, differentiation and tension generation 
are critical aspects of wound healing and tissue remodeling. This study will help improve 
the knowledge of bacterial association in the wound as both planktonic and biofilm state 
and might help to reduce infection on a chronic wound. We can support the healing 
regeneration which restores normal wound healing that might contribute a better 
understanding to the scientific community. Further understanding of molecular properties 
and finding the pathway of inhibition by S. aureus PCM on fibroblast is in progress. This 
study will help narrow the role of planktonic and biofilm bacterial role in pathogenicity 
towards chronic wound healing. The breaking down of biofilm by biofilm disturbing 
enzymes (Izano et al., 2008) and treating the fibroblast collagen lattice is already in 
progress. For further biofilm investigations, we can work with co-culture model where 
biofilm tissue culture will be sitting on top of the collagen lattice. This way biofilm effect 
on fibroblast cell is direct, where we can assess fibroblast function more closely like in 
chronic wound. These studies will further advance the knowledge and foster future research 
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Figure 1. Distribution of cells is affected by mixing time. After lattices had polymerized 
and media was added, images were taken of the plate beneath the lattices. When lattices 
were plated early, more cells appeared on the plate (A, left); after a sufficient amount of 
mixing time, the number of cells remained constantly low (A, right). Lattices that were 
DAPI-stained and imaged with confocal laser microscopy showed the effect of mixing 
time; lattices plated immediately showed the majority of cells in the lower half of the lattice 









Figure 2:  Cell appearance below the lattices was reduced over time. Graphed results of 
replicate images similar to figure 1 A were averaged. For this experiment, the cell 














































Figure 3 A: Collagen consistency changes with mixing. When the collagen/ cell mixture 
is plated early, the collagen appears homogenous, without fibers showing (left image); after 
a longer mixing time, fibers begin to appear in the collagen (arrow in the right image). 
 
Figure 3 B: Collagen texture contrast increases with mixing time. Numerous images were 
analyzed using the Image J GLCM plugin, and the contrast values were combined and 
averaged. Contrast values, and therefore flocculence, began to increase after 7 minutes, 

































Figure 4: Graph overlay for cell escape and flocculence provides the optimum plating time 
to reduce both effects. Based on this set of data, the collagen lattices should be plated 












Figure 5: Raw mean height over time for the fibroblast collagen lattices treated with PCM 
tends to have the highest height throughout day 5. PCM inhibited the fibroblast collagen 
lattice compaction significantly compared to BCM, Control and TGF-Beta. Our result 
represents the replicates of four sample for each treatment. The mean height of all 
treatments was significantly different (p< 0.001) from each other resulting the PCM to have 


































Figure 6: PCM inhibited the contraction of fibroblast collagen lattices when released at 
day 5. PCM-treated lattices significantly reduced contraction of the lattice diameter at each 
time point 1, 2, 10, 30 and 60 minutes from other treatments BCM, Control and TGF-β. 
We also observed that BCM-treated lattices were significantly different (p< 0.001) from 
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Table 1. Total number of cells phenotype with respect to their treatments. 
 
Cell Type Control BCM PCM TGF-β 
Non-proliferating fibroblasts (NPF)  160 187  78  162  
Proliferating fibroblasts (PF)  40  31  9  47 
Non-proliferating myofibroblasts (NPMF)  52  41  18  100  
Proliferating myofibroblasts (PMF)  19  16  1  39 
 
 Control BCM PCM TGF-β 
 
Total number of 
cells: 
271 275 106 348 
Myofibroblast 
percentage: 




Figure 7: Four different cell phenotypes were observed. Each field of view images were 
collected using the blue (dapi-nuclei counter stain), red (EdU-proliferation) and the green 
(α-sma- differentiation) filter. The images were combined that identified for four different 
cell phenotypes: non-proliferative fibroblasts (open arrowhead), proliferative fibroblasts 
(solid arrowhead), non-proliferative myofibroblasts (open arrow) and proliferative 




Figure 8: This is the ELISA results for PCM, BCM and control. BCM has high production 
of IL8/CXCL8 than compared to PCM and control. Analysis of variance (ANOVA) was 
performed to observe statistical difference. The values represent the mean of three 
independent experiments. There is a significant difference (p<0.05) between the groups. 


















































Figure 9: A diagram scheme for the fibroblast role in wound healing. A:  Tension 
generation allows a fibroblast to differentiate into a myofibroblast and cell locomotion 
supports reorganization of collagen that results in wound closure. B. In our scenario where 
fibroblasts were exposed to planktonic secretion products (PCM,) no myofibroblasts were 
produced because of lack of permissive environment with no tension generation. Without 
cell locomotion or reorganization of collagen, would healing would be prolonged with no 
contraction of wound.  
Fibroblast 
Myofibroblast and number 
of cells 
 
wound healing  
Fibroblast 
No myofibroblasts and 
few cells  



















Figure 10: This graph demonstrates compaction effects due to HaCaT- conditioned 
medium. Under control conditions, compaction occurs in an asymptotic manner (blue line) 
over 5 days. Mean averages of four replicates for each treatment were used. PCM exposed 
to HaCaT-conditioning medium greatly reduced the compaction (grey line) while BCM 






























Figure 11: PCM greatly inhibited fibroblast populated collagen lattice contraction, 
indicating little or no force generation. BCM was slightly inhibitory while control lattices 

































Table 2.  Total number of cells by type and treatment for HaCaT treatments 
 
 
Cell Type measured Control BCM PCM  
Non-proliferating fibroblasts (NPF)  329 266 141    
Proliferating fibroblasts (PF)  33  29  9   
Non-proliferating myofibroblasts (NPMF)  53  35 12   
Proliferating myofibroblasts (PMF)  13   8 0   
           
 
 
Control BCM     PCM    
Total number of cells:  428     338     162                
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